Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
For visual reference only; actual product may vary
Gilenya (fingolimod) is an oral medication used to treat relapsing forms of multiple sclerosis (MS) in adults and children over ten. It helps reduce relapse frequency and slows disability progression by preventing inflammatory cells from reaching the nervous system.
| Gilenya Brand | 0.5mg 28 Tablets |
-
|
Our price: $3,200.00 |
|
| Fingya Generic | 0.5mg 28 Capsules |
-
|
Our price: $737.00 |
Gilenya is a prescription oral medication used to manage relapsing forms of multiple sclerosis. It is approved for adults and children who are at least 10 years old. This treatment is specifically for clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS). Gilenya helps to reduce the frequency of MS relapses. It also slows the buildup of physical problems caused by MS. By managing symptoms, it can improve quality of life for patients. The medication is taken as a once-daily capsule.
Gilenya works by changing how the immune system functions. Its active ingredient, fingolimod, is a sphingosine 1-phosphate receptor modulator. It traps certain white blood cells (lymphocytes) in the body’s lymph nodes. This action prevents them from entering the central nervous system, which includes the brain and spinal cord. By limiting these inflammatory cells, Gilenya reduces nerve damage. This process helps to decrease the number and severity of MS flare-ups. It ultimately slows the progression of the disease over time.
Gilenya is for adults and children aged 10 and older diagnosed with relapsing forms of multiple sclerosis. This includes patients experiencing their first episode of symptoms, known as CIS. It also includes those with relapsing-remitting MS, the most common form of the disease. Furthermore, it is prescribed for active secondary progressive MS. People with this condition experience a steady worsening of their disability. In some cases, doctors may also prescribe it for chronic inflammatory demyelinating polyneuropathy (CIDP). This is a rare autoimmune disorder affecting the peripheral nerves. A doctor must determine if Gilenya is appropriate for you.
Gilenya dosage and administration involves taking one capsule by mouth, once per day. You can take the capsule with or without food as directed by your healthcare provider. It is very important to take Gilenya exactly as prescribed. Do not change your dose or stop taking it without consulting your doctor. The first dose of Gilenya requires medical supervision. Your heart rate and blood pressure will be monitored for at least six hours. This is a safety precaution because the medication can cause a temporary slowing of the heart rate. Always follow your doctor’s instructions carefully for safe and effective treatment.
Gilenya may cause a range of side effects, from common to serious. Common side effects often include headache, diarrhea, cough, and back pain. These symptoms are usually mild and may lessen over time. However, Gilenya carries risks of more serious side effects. These include an increased risk of infections and a rare brain infection called PML. Other potential issues are vision problems, liver damage, and temporary heart rate slowing. It is critical to discuss all potential risks with your doctor. Contact your healthcare provider immediately if you experience any severe or unusual symptoms while taking Gilenya.
Buying Gilenya from IsraelPharm provides a reliable and affordable option for your treatment. We are committed to making essential medications accessible. Our platform allows you to purchase brand-name drugs at competitive prices. You can conveniently order your prescription from home. We ensure every medication is sourced from trusted manufacturers. Our customer service team is available to assist you with your order. You get the benefit of significant savings without compromising on quality or safety. Trust IsraelPharm for a seamless and secure purchasing experience.
Many people using Gilenya do not have serious side effects. The more common side effects may include:
Gilenya may cause serious side effects. Contact your doctor immediately if you experience any of the following:
Gilenya is prescribed for the treatment of relapsing forms of multiple sclerosis (MS) in adults and children 10 years and older, including:
It may also be prescribed for chronic inflammatory demyelinating polyneuropathy (CIDP).
Gilenya begins working after the first dose to alter your immune response, but its clinical benefits are not immediate. It starts to reduce the number of lymphocytes in the blood within hours. Patients may start to notice a reduction in MS relapses and a slowing of disability progression over several months of consistent daily use. The full effect of Gilenya is part of a long-term treatment strategy to manage multiple sclerosis effectively.
If you miss one dose of Gilenya, you should take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and resume your normal schedule. If you miss one or more days of treatment, you must call your doctor. Restarting Gilenya after a pause may require another first-dose observation period due to the risk of heart rate changes.
Gilenya should not be stopped without first consulting your healthcare provider. Abruptly discontinuing the medication can lead to a severe worsening of MS symptoms, sometimes making them worse than before starting treatment. Your doctor will provide guidance on how to safely stop Gilenya if necessary and may transition you to another therapy while monitoring you closely for any rebound effects.
Before starting Gilenya, your doctor will perform several important tests. This includes a recent complete blood count (CBC) and liver function tests. An ophthalmologist will perform an eye exam to check for macular edema. You will also need an electrocardiogram (ECG) to check your heart's electrical activity. This baseline monitoring is essential to ensure Gilenya is a safe treatment option for you.
Gilenya and alcohol can both potentially affect the liver. While moderate alcohol consumption is not strictly forbidden, you should discuss it with your doctor. Your doctor will monitor your liver function with blood tests during treatment. Excessive alcohol use should be avoided to reduce the risk of liver injury. Always be transparent with your healthcare provider about your alcohol intake while on Gilenya treatment.
Gilenya does not cure multiple sclerosis. It is a disease-modifying therapy designed to manage the condition long-term. By reducing the frequency and severity of relapses and slowing the progression of disability, Gilenya helps to improve the overall quality of life for people with MS. It is an effective tool for controlling the disease, but it is not a cure for it.
Gilenya can make vaccines less effective and you should avoid "live" vaccines during treatment. Live vaccines contain a weakened form of a virus and could cause a serious infection in people with a suppressed immune system. It is important to complete any needed vaccinations at least one month before starting Gilenya. Always talk to your doctor before receiving any vaccine while on this medication.
Gilenya should be stored at room temperature, between 68°F and 77°F (20°C and 25°C). Keep the capsules in their original blister pack until you are ready to take one. This protects them from light and moisture. As with all medications, it is crucial to store Gilenya out of the reach of children and pets to prevent accidental ingestion.
Gilenya is not a type of chemotherapy. It is a targeted immunotherapy known as a sphingosine 1-phosphate receptor modulator. While it does suppress part of the immune system to treat multiple sclerosis, its mechanism is very different from traditional chemotherapy drugs used to treat cancer. Gilenya works specifically on lymphocytes involved in the MS disease process.
Gilenya requires monitoring for at least six hours after the first dose because it can cause a temporary decrease in heart rate. This safety measure is performed in a medical setting where your heart rate and blood pressure can be checked hourly. An ECG is also done before the first dose and at the end of the observation period to ensure your heart is responding safely to the medication.
Gilenya may increase your risk of developing certain types of skin cancer, including basal cell carcinoma and melanoma. It is important to protect your skin from the sun by wearing protective clothing and using a broad-spectrum sunscreen. You should also perform regular skin self-exams and report any new skin growths, sores that won’t heal, or changes in moles to your doctor promptly.
Gilenya can increase the risk of developing macular edema, which is swelling in the back of the eye that affects central vision. Symptoms may include blurriness, shadows, or a blind spot. An eye exam is required before starting treatment and should be repeated 3-4 months after starting. Report any changes in your vision to your healthcare provider immediately, as this condition requires medical attention.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name
You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and
People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk
